Tempus AI vs Zoetis Inc — how do they compare? Tempus AI trades at $55.7 (market cap $10.05B), while Zoetis Inc trades at $75.11 (market cap $31.14B). The key difference: Zoetis Inc is far larger — about 3.1× Tempus AI's market cap, and Zoetis Inc pays a 2.81% dividend while Tempus AI pays none. Which is the better fit depends on your goals.
| TEM | ZTS | |
|---|---|---|
Market Cap | $10.05B | $31.14B |
Sector | Broad Market / Factor | Health |
52-Week High | $103.25 | $156.76 |
52-Week Low | $41.55 | $71.91 |
Enterprise Value | $10.68B | $38.70B |
Dividend Yield | — | 2.81% |
Trailing returns across standard periods
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
Read more on TEM →Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
Read more on ZTS →